Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

861 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhancing the diagnostic capacity of [18F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study.
Glemser PA, Freitag M, Kovacs B, Netzer N, Dimitrakopoulou-Strauss A, Haberkorn U, Maier-Hein K, Schwab C, Duensing S, Beuthien-Baumann B, Schlemmer HP, Bonekamp D, Giesel F, Sachpekidis C. Glemser PA, et al. Among authors: schwab c. EJNMMI Rep. 2024 Nov 8;8(1):37. doi: 10.1186/s41824-024-00225-5. EJNMMI Rep. 2024. PMID: 39510993 Free PMC article.
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
Radtke JP, Hadaschik BA, Wolf MB, Freitag MT, Schwab C, Alt C, Roth W, Duensing S, Pahernik SA, Roethke MC, Schlemmer HP, Hohenfellner M, Teber D. Radtke JP, et al. Among authors: schwab c. J Endourol. 2015 Dec;29(12):1396-405. doi: 10.1089/end.2015.0358. Epub 2015 Aug 20. J Endourol. 2015. PMID: 26154571
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP, Schwab C, Wolf MB, Freitag MT, Alt CD, Kesch C, Popeneciu IV, Huettenbrink C, Gasch C, Klein T, Bonekamp D, Duensing S, Roth W, Schueler S, Stock C, Schlemmer HP, Roethke M, Hohenfellner M, Hadaschik BA. Radtke JP, et al. Among authors: schwab c. Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19. Eur Urol. 2016. PMID: 26810346
Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing.
Talla SB, Rempel E, Endris V, Jenzer M, Allgäuer M, Schwab C, Kazdal D, Stögbauer F, Volckmar AL, Kocsmar I, Neumann O, Schirmacher P, Zschäbitz S, Duensing S, Budczies J, Stenzinger A, Kirchner M. Talla SB, et al. Among authors: schwab c. Genes Chromosomes Cancer. 2020 Jul;59(7):406-416. doi: 10.1002/gcc.22843. Epub 2020 Apr 17. Genes Chromosomes Cancer. 2020. PMID: 32212351
Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence.
Sprute K, Kramer V, Koerber SA, Meneses M, Fernandez R, Soza-Ried C, Eiber M, Weber WA, Rauscher I, Rahbar K, Schaefers M, Watabe T, Uemura M, Naka S, Nonomura N, Hatazawa J, Schwab C, Schütz V, Hohenfellner M, Holland-Letz T, Debus J, Kratochwil C, Amaral H, Choyke PL, Haberkorn U, Sandoval C, Giesel FL. Sprute K, et al. Among authors: schwab c. J Nucl Med. 2021 Feb;62(2):208-213. doi: 10.2967/jnumed.120.246363. Epub 2020 Aug 17. J Nucl Med. 2021. PMID: 32817141 Free PMC article.
Fully Automatic Deep Learning in Bi-institutional Prostate Magnetic Resonance Imaging: Effects of Cohort Size and Heterogeneity.
Netzer N, Weißer C, Schelb P, Wang X, Qin X, Görtz M, Schütz V, Radtke JP, Hielscher T, Schwab C, Stenzinger A, Kuder TA, Gnirs R, Hohenfellner M, Schlemmer HP, Maier-Hein KH, Bonekamp D. Netzer N, et al. Among authors: schwab c. Invest Radiol. 2021 Dec 1;56(12):799-808. doi: 10.1097/RLI.0000000000000791. Invest Radiol. 2021. PMID: 34049336
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer.
Nientiedt C, Budczies J, Endris V, Kirchner M, Schwab C, Jurcic C, Behnisch R, Hoveida S, Lantwin P, Kaczorowski A, Geisler C, Dieffenbacher S, Falkenbach F, Franke D, Görtz M, Heller M, Himmelsbach R, Pecqueux C, Rath M, Reimold P, Schütz V, Simunovic I, Walter E, Hofer L, Gasch C, Schönberg G, Pursche L, Hatiboglu G, Nyarangi-Dix J, Sültmann H, Zschäbitz S, Koerber SA, Jäger D, Debus J, Duensing A, Schirmacher P, Hohenfellner M, Stenzinger A, Duensing S. Nientiedt C, et al. Among authors: schwab c. Urol Oncol. 2022 Jan;40(1):8.e11-8.e18. doi: 10.1016/j.urolonc.2021.06.024. Epub 2021 Jul 26. Urol Oncol. 2022. PMID: 34325986 Free article.
861 results